MN PHARMA INTERNATIONAL LIMITED - LONDON
Company Profile | Company Filings |
Overview
MN PHARMA INTERNATIONAL LIMITED is a Private Limited Company from LONDON ENGLAND and has the status: Active.
MN PHARMA INTERNATIONAL LIMITED was incorporated 1 years ago on 18/02/2023 and has the registered number: 14673845. The accounts status is NO ACCOUNTS FILED and accounts are next due on 18/11/2024.
MN PHARMA INTERNATIONAL LIMITED was incorporated 1 years ago on 18/02/2023 and has the registered number: 14673845. The accounts status is NO ACCOUNTS FILED and accounts are next due on 18/11/2024.
MN PHARMA INTERNATIONAL LIMITED - LONDON
This company is listed in the following categories:
46460 - Wholesale of pharmaceutical goods
46460 - Wholesale of pharmaceutical goods
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
28 / 2 | 18/11/2024 |
Registered Office
925 FINCHLEY ROAD
LONDON
NW11 7PE
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
01/11/2023 | 15/11/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MRS MANJINDER KOHLI | Jan 1964 | British | Director | 2023-10-27 | CURRENT |
MR NARINDER SINGH KOHLI | Secretary | 2023-10-26 | CURRENT | ||
MISS CHANDNI PARESH PATEL | Dec 1992 | British | Director | 2023-02-18 UNTIL 2023-11-01 | RESIGNED |
MR PARESH KUMAR INDUPRASAD PATEL | Feb 1953 | British | Director | 2023-02-18 UNTIL 2023-11-01 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Mrs Manjinder Kaur Kohli | 2023-11-01 | 1/1964 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors |
Mr Narinder Singh Kohli | 2023-11-01 | 7/1964 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors |
Glosgrange Limited | 2023-02-18 - 2023-11-01 | Edgware |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |